Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $392.5 million.

  • Merit Medical Systems' Cash & Equivalents fell 2497.88% to $392.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $392.5 million, marking a year-over-year decrease of 2497.88%. This contributed to the annual value of $376.7 million for FY2024, which is 3582.76% down from last year.
  • As of Q3 2025, Merit Medical Systems' Cash & Equivalents stood at $392.5 million, which was down 2497.88% from $341.8 million recorded in Q2 2025.
  • Over the past 5 years, Merit Medical Systems' Cash & Equivalents peaked at $636.7 million during Q2 2024, and registered a low of $51.5 million during Q3 2022.
  • Its 5-year average for Cash & Equivalents is $237.7 million, with a median of $69.7 million in 2021.
  • In the last 5 years, Merit Medical Systems' Cash & Equivalents skyrocketed by 90506.1% in 2023 and then plummeted by 4631.04% in 2025.
  • Merit Medical Systems' Cash & Equivalents (Quarter) stood at $67.8 million in 2021, then fell by 13.79% to $58.4 million in 2022, then surged by 905.06% to $587.0 million in 2023, then tumbled by 35.83% to $376.7 million in 2024, then increased by 4.18% to $392.5 million in 2025.
  • Its last three reported values are $392.5 million in Q3 2025, $341.8 million for Q2 2025, and $395.5 million during Q1 2025.